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MalignantAbstract Aim: Evaluate the role of ADC value measurements in the differentiation between
benign and malignant neck masses.
Methods: From April 2011 to February 2013, prospective study was conducted on 30 patients (17
male and 13 female), with the mean age 43.3 ± 6 years. Collected from wards and clinics of General
Surgery and Otolaryngology Departments complaining from neck masses. MRI, Diffusion-
Weighted Imaging (b value 0, 100, 500 and 1000 s/mm) and ADC value calculation were performed
and the results were correlated with histopathological results and/or follow up.
Results: The present study include 30 patients (Lymphadenopathy {(n= 15) (11 as single entity),
(4 associated with other entities)}, Focal thyroid swelling (n= 5), Salivary gland masses (n= 3)
{Parotitis (1 case), Parotid carcinoma (2 cases)}, Nasopharyngeal masses (n= 5), Oropharyngeal
masses (n= 2), Ludwig angina (n= 2) and Laryngeal masses (n= 2).
The mean ADC of the malignant neck masses was (0.699 + 0.267 · 10-3 mm2/s) while that of the
benign masses was (1.879 + 0.751 · 10-3 mm2/s).
368 F. Salem et al.The results conﬁrmed by biopsy in 23 cases and follow up (7 cases).
The sensitivity, speciﬁcity, PPV, NPV and overall accuracy of quantitative diffusion WI in differ-
entiating benign from malignant neck masses were 95.4%, 83.3%, 95.4%, 83%, and 92%.
Conclusion: ADC value calculation are promising noninvasive imaging approach that can be used
in distinguishing between benign and malignant neck masses. Benign lesions have higher mean ADC
values than malignant lesions, the cutoff value was 1.25 · 10-3 mm2/s while 0.8 · 10-3 mm2/s in
thyroid lesions.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Head and neck masses are a common clinical concern in differ-
ent age groups. The differential diagnosis for a head or neck
mass across these age groups is broad and includes congenital,
inﬂammatory, and neoplastic lesions (1).
Conventional MRI and CT continue to be the primary
imaging modalities for evaluating head and neck cancers.
However, both of these modalities rely on volumetric and mor-
phological criteria and consequently suffer from low sensitivity
and accuracy when making the diagnosis (2,3).
DWI and apparent diffusion coefﬁcient (ADC) measure-
ments are being considered as potentially useful in the evalua-
tion and characterization of head and neck lesions (4).
Diffusion-Weighted Imaging (DWI) plays an important role
in the diagnosis, prognosis and monitoring of treatment
response in tumors arising in the head and neck region (5,6).
It is able to distinguish between the viable and necrotic portions
of head and neck tumors. Also, DWI is indicated for character-
izing lesions in children avoiding the use of contrast (7).
The apparent diffusion coefﬁcient (ADC) value, determined
from DWI, can help in cancer staging and detection of subcen-
timeter nodal metastasis. The ADC value also discriminates
carcinomas from lymphomas, benign lesions from malignant
tumors and tumor necrosis from abscesses (8,9).
Moreover, differentiation between the different subtypes of
squamous cell carcinoma (SCC) is possible using ADC
measurements (10). Low pretreatment ADC values typically
predict a favorable response to chemoradiation therapy (6).
Furthermore, Diffusion-Weighted Imaging is a very useful
tool in the distinction between irradiation effects and recurrent
tumor (11). It is probably the best imaging technique for nodal
staging and the presence or absence of distant metastatic nodes
in the head and neck region, and is able to accurately differen-
tiate benign and malignant lymph nodes (6).
The aim of this work is to evaluate the role of ADC value
measurements in the differentiation between benign and malig-
nant neck masses.
2. Materials and methods
Research Ethics Committee (REC) approval and written in-
formed consent were obtained.
From April 2011 to February 2013, a prospective study was
conducted on 30 patients (17 male and 13 female), age range
from 12 years to 78 years with the mean age 43.3 + 6 years.
Collected from wards and clinics of General Surgery and Oto-
laryngology Departments complaining from neck masses.
Conventional MRI and Diffusion-Weighted Imaging (b value0, 100, 500 and 1000 s/mm) were performed and the results
were correlated with histopathological results (23 cases) and
follow up in 7 cases.
2.1. MR examination
2.1.1. Patient positioning
All MR examinations were done with the patient in the supine
position and immobilized in a comfortable position using
surface head and neck coil from the skull base up to the
thoracic inlet.
All MR images were performed with 1.5-T MRI system
(Signa; GE Medical Systems,) in the MRI unit of the Radiodi-
agnosis and Imaging Department.
For all patients, the imaging protocol consisted of using
fast spin echo pulse sequences with different repetition time
(TR) and echo delay time (TE) to obtain T1 and T2 WI as
follow:
A scout T1 WI sagittal view to verify the precise position of
lesion.
The routine imaging studies included MRI. Routine spin
echo (SE) T2 (TR/TE 2200/80) and T1 weighted (TR/
TE = 660/15) images were obtained in the axial coronal and
sagittal planes, contrast material (Gadopentetate Dimeglumine
diethylenetriamine penta-acetic acid (Gd DPTA)) (Magnevist)
injected IV (18 cases) with a dose of (0.1 mmol/kg).
The imaging data were reviewed by two radiologists with
no knowledge of the primary lesion; they reached a consensus
opinion before reviewing the pathology results. The lesion con-
tour, size, intensity, extensions and pattern of enhancement
were recorded.
3. Diffusion-Weighted Imaging and apparent diffusion
coefﬁcient mapping
Diffusion-Weighted Imaging was performed in the transverse
plane by using an SE echo-planar imaging sequence with the
following parameters: TR/TE/TI (inversion time), 12,000/95/
2200 ms; diffusion gradient encoding in three orthogonal direc-
tions; b values were 0, 100, 500, 1000 s/mm; FOV, 24 · 24 cm;
matrix size, 128 · 256 pixels; section thickness, 5 mm; section
gap, 2.5 mm. An ADC map was obtained. In quantitative
study, an imaging slice was chosen, multiple (1 to 2 cm) circu-
lar region of interest (23 cases) or one large ROI (7 cases)
(according to the size and heterogeneity of the mass) were
located on the lesions detected as well as the normal part or
contralateral side if present, ROIs were not positioned in the
cystic or necrotic portion identiﬁed on the T2-weighted images
and the contrast enhanced T1-weighted images because this
Table 1 Statistical analysis for use of ADC values in discriminating benign neck masses from malignant.
ADC value · 10-3mm2/s Sensitivity (%) Speciﬁcity (%) Accuracy (%) PPV (%) NPV (%)
<0.66 46 100 86 100 84
<1 69 89 84 69 89
<1.25 95.4 83.3 92 95.4 83
<2.5 100 64 73 36 100
Table 2 Mean apparent diffusion coefﬁcients (ADCs) values of the neck masses in this study.
Type of lesion Mean ADC
(b value = 100)
Mean ADC
(b value = 500)
Mean ADC
(b value = 1000)
+SD P Sig.
Lymphadenopathy NHL 0.93 0.75 0.61 0.09 0.025 S
Metastatic 1.25 0.94 0.87 0.07 0.052 Ns
Reactive 1.91 1.83 1.77 – – –
Benign thyroid nodules 2.35 1.97 1.82 0.13 0.086 Ns
Malignant thyroid nodules 0.61 0.82 0.6 0.14 0.091 Ns
Parotitis 1.8 1.91 1.99 – – –
Parotid carcinoma 0.91 0.82 0.71 0.17 0.052 Ns
Nasopharyngeal Carcinoma 0.64 0.61 0.62 0.17 0.019 S
Lymphoma 0.52 0.57 0.52 0.08 0.018 S
Oropharyngeal Carcinoma 0.81 0.72 0.61 – 0.017 S
Lymphoma 0.41 0.45 0.44 – 0.019 S
Ludwig angina 2.02 2.01 2.00 0.08 0.085 Ns
Laryngeal carcinoma 0.82 0.88 0.9 0.06 0.017 S
Mean ADC value = · 10 -3mm2/s.
b value = s/mm.
The difference between the mean ADC values of benign and malignant lesions was statistically signiﬁcant. No statistically signiﬁcant differences
in ADC values among the different benign lesions or among the different malignant lesions at both sequences.
SD = Standard Deviation, S = Signiﬁcant, Ns = Non-Signiﬁcant.
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tion (SD) of ADC values were calculated.
Mean ADC value is calculated by using the following equa-
tion (12):
ADC= ln[S1/S2]/b2b1, where S1 and S2 are the signal
intensities measured on diffusion weighted MR images ob-
tained with a lower b factor (b1) and a higher b factor (b2).
The diagnosis was done by gathering ﬁndings of conven-
tional MRI and quantitative Diffusion-Weighted Imaging.
The diagnosis was conﬁrmed histopathologically in 23 cases
and follow up in 7 cases (5 cases metastatic, 2 cases need med-
ical treatment).
3.1. Statistical analysis
Statistical presentation and analysis of the present study was
conducted, using the mean and standard deviation by SPSS
V.16. Analysis of variance [ANOVA] tests and Tukey’s test
was used to determine the signiﬁcance between two groups:
According to the computer program SPSS for Windows. AN-
OVA test was used for comparison among different times in
the same group in quantitative data. P value <0.05 was con-
sidered signiﬁcant.
Receiver-operating-characteristic (ROC) curve analysis by
using continuous data with a maximum likelihood method
was used to investigate the discriminatory capability of the
ADCs in differentiating benign and malignant neck masses.The area under the ROC curve was calculated. The ADC value
that corresponded to the highest Yoden index (sensitiv-
ity + speciﬁcity – 1) and highest accuracy was chosen as the
optimal ADC threshold value because it optimized both the
sensitivity and speciﬁcity.4. Results
The present study included 30 patients with neck masses
including 15 cases (50%) of lymph node swellings (8 cases
NHL, 6 cases metastatic lymph node, 1 case reactive lymph
node) {(11 as single entity), (4 associated with other entities
(Nasopharyngeal carcinoma (1 case), Parotitis (1 case), Thy-
roid carcinoma (1 case) and Ludwig angina (1 case))}, 5 cases
(16.6%) of Focal thyroid lesion {Follicular adenoma (1 case),
Thyroid nodules associated with Hashimoto thyroiditis
(1 case) and Papillary carcinoma (3 cases)}, 3 cases with Sali-
vary gland masses (10%) {Parotitis (1 case), Parotid carcinoma
(2 cases)}, 5 cases Nasopharyngeal masses (16.6%) {Nasopha-
ryngeal carcinoma (3 cases), Nasopharyngeal lymphoma
(2 case)}, 2 cases Oropharyngeal masses (6.6%) {(Carcinoma
(1 case), Lymphoma (1 case)}, 2 cases Ludwig angina (6.6%)
and 2 cases Laryngeal carcinoma (6.6%). The overall malig-
nant tumors (24 cases) and benign tumors (6 cases).
ROC analysis showed that the area under the curve was
0.946 and the optimum threshold for the ADC was
370 F. Salem et al.1.25 · 10-3 mm2/s (with b value 1000), resulting in a sensitivity
of 95.4%, a speciﬁcity of 83.3%, and an accuracy of 92%.
Two exception from this threshold value were, 1 case of be-
nign thyroid adenomatous nodules (ADC value 1.1), due to
high cellular component of the nodule, and 1 case of squamous
cell carcinoma of the oropharynx (ADC value 1.4), so the
threshold value for predicting malignancy was 0.8 · 10-3
mm2/s in thyroid lesions.
Statistical analysis for use of ADC value in discriminating
benign neck masses from malignant were shown in (Table 1).
The lowest ADC values of malignant tumors were detected
in oropharyngeal lymphoma (0.44 ± 0.17 · 10-3mm2/s),
while the highest in metastatic lymphadenopathy
(0.87 ± 0.07 · 10-3mm2/s).Table 3 Classiﬁcations of diseases areas (34 lesions) on the basis o
Extremely low ADC Low
<0.6 · 10-3mm2/s 0.6- < 1.2 · 10-3 mm2/s
7 cases (20.5%) 15 cases (44.1%)
Fig. 1 Oropharyngeal lymphoma: 71 years-old female, axial T2 WI
mucosal space extending to masticator space), mean ADC value was 0
WI, (c) ADC map.Mean apparent diffusion coefﬁcients (ADCs) values (using
different b values) of the neck masses in this study were shown
in (Table 2).
We classiﬁed the disease areas into four categories on the
basis of ADC levels: extremely low ADC (<0.6 · 10-3 mm2/
s) (7 cases), low ADC (0.6– < 1.2 · 10-3 mm2/s) (15 cases),
intermediate ADC (1.2– < 1.8 · 10-3 mm2/s) (8 cases), and
high ADC (>1.8 · 10-3 mm2/s) (4 cases) (Table 3). This classi-
ﬁcation is effective in differentiation between benign and
malignant tumors and can predict local control in patients
treated with chemoradiation (11).
We can differentiate between Lymphoma and squamous
cell carcinoma of oropharynx and nasopharynx by their
distinctive ADCs, as lymphoma shows lower ADCsf ADC levels.
Intermediate High
1.2- < 1.8 · 10-3 mm2/s >1.8 · 10-3 mm2/s
8 cases (23.5%) 4 cases (11.7%)
shows heterogeneous soft tissue mass in oropharynx (pharyngeal
.27 · 10-3 mm2/s (extremely low ADC). (a) Axial T2, (b) Diffusion
Fig. 2 Nasopharyngeal lymphoma: 46 years-old male, axial T2 WI shows well deﬁned homogenously isointense soft tissue mass in
nasopharynx (suprahyoid visceral neck space), mean ADC value was 0.5 · 10-3 mm2/s (extremely low ADC). (a) Axial T2, (b) Diffusion
WI, (c) ADC map.
Apparent diffusion coefﬁcient measurements in the differentiation between benign and malignant neck masses 371(0.52+ 0.08 · 10-3 mm2/s in NPC and 0.44+ 0.17 · 10-3 mm2/s in
oropharyngeal carcinoma) than SCC (0.62+ 0.17 · 10-3 mm2/s in
NPC and 0.61 + 0.18 · 10-3 mm2/s in oropharyngeal carci-
noma) with heterogeneous SI in T2 WI of SCC and homoge-
nous SI in lymphoma (Figs. 1 and 2).
The ADC of the malignant thyroid nodules were
(0.6 + 0.14 · 10-3 mm2/s) while that of the benign thyroid
nodules was (1.82 + 0.13 · 10-3 mm2/s) (The difference be-
tween the mean ADC values of benign and malignant thyroid
lesions was statistically signiﬁcant (P< 0.001). No statistically
signiﬁcant differences in ADC values among the different be-
nign lesions or among the different malignant lesions (Fig. 3).
The mean of ADC value of parotitis was 1.9 · 10-3 mm2/s,
while the mean ADC value of the parotid cancer patients
0.7 ± 0.17 · 10-3 mm2/s (Fig. 4).
Quantitative diffusion (ADC value measurements) is excel-
lent methods for nodal differentiation and staging, benign
lymph node showed higher ADC value than metastatic ones
while the lowest ADC values of lymphadenopathy weredetected in lymphoma. The mean ADC values of the reactive,
metastasis and lymphoma groups were 1.7 · 10-3,
0.87 ± 0.07 · 10-3 and 0.6 ± 0.09 · 10-3 mm2/s, respectively.
The best ADC threshold value for distinguishing benign and
malignant nodes was 1.25 · 10-3 mm2/s (Fig. 5).5. Discussion
MRI of the head and neck had developed signiﬁcantly with the
advent of Diffusion MRI. This modality has been used to dis-
criminate carcinomas from lymphomas, benign from malig-
nant tumors and necrosis from abscesses of the head and
neck region. In general, malignant tumors have lower apparent
diffusion coefﬁcient (ADC) values compared with benign
tumors (13).
The aim of this study is to evaluate the role of ADC value
measurements in the differentiation between benign and
malignant neck masses.
Fig. 3 Multiple thyroid nodules in patient with Hashimoto’s thyroiditis: 20 years-old female, axial T2 WI shows hyperintense nodular
enlargement in both thyroid lobes (in infrahyoid visceral space of the neck), mean ADC value was 2.6 · 10-3 mm2/s (high ADC). (a) Axial
T2, (b and c) Diffusion WI, (d) ADC map.
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of lymph nodes in the head and neck region (13).
This study included 15 patients with enlarged lymph nodes
(8 (53.3%) cases lymphoma, 6 (40%) cases metastatic lymph
nodes and 1 (6.7%) case with reactive lymphadenopathy).
The mean ADC value in the 8 cases of NHL was 0.61 · 10-3
mm2/s, while 0.87 · 10-3 mm2/s in the 6 cases of metastatic
lymphadenopathy and 1.7 · 10-3 mm2/s in reactive lymphade-
nopathy. We use an ADC value 1.25 · 10-3 mm2/s or less for
predicting malignancy.
While this results slightly different from Goncalves et al.
(14) who study 55 enlarged LN in 35 patients. These enlargedLN were either secondary to malignancy or were benign/reac-
tive. In their study, DWI was able to depict all abnormal LN
that were seen in other sequences. According to their study,
malignant LN had lower ADC values, with mean of
0.74 · 10-3 mm2/s. ADC in LN with SCCA metastasis ranged
from 0.62 · 10-3 mm2/s to 0.93 · 10-3 mm2/s. In LN with lym-
phoma, the mean ADC was 0.64 ± 0.09 · 10-3 mm2/s. The
ADC threshold to differentiate benign from malignant LN
was 1.02 · 10-3 mm2/s.
De Bondt et al. (15) have also concluded that ADC is useful
in the assessment of LN. They have demonstrated that LN
metastasis had signiﬁcantly lower ADC values as compared
Fig. 4 Parotid mucoepidermoid carcinoma: 65 years-old female, axial T2 WI shows hyperintense ill-deﬁned mass is seen in right parotid
space extend to submandibular and right parapharyngeal spaces, minimum ADC value was 0.9 · 10-3 mm2/s (low ADC). (a) Axial T2, (b
and c) Diffusion WI, (d) ADC map.
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fully discriminated inﬂammatory from metastatic LN lympho-
mas had the lowest ADC values.This study included 5 patients with focal thyroid swelling,
one patient with follicular adenoma, one patient with thyroid
nodules associated with Hashimoto thyroiditis and 3 patients
Fig. 5 Non-Hodgkin’s lymphoma: 65 years-old female, axial T2 WI shows amalgamated heterogenous mass is seen in left
submandibular space extends to left carotid and posterior cervices spaces with multiple areas of internal degeneration, mean ADC value of
the solid part was 0.6 · 10-3 mm2/s (low ADC). (a) Axial T2, (b) Diffusion WI, (c) ADC map.
374 F. Salem et al.with papillary carcinoma. Signiﬁcant difference in ADC value
of benign and malignant thyroid nodules, all benign nodules
had higher mean ADC values (1.8 ± 0.13 · 10-3 mm2/s) com-
pared with the malignant ones (0.6 ± 0.14 · 10-3 mm2/s).
An ADC value of 0.8 · 10-3 mm2/s or less could be used as
an indicator of malignancy because of highly cellular ade-
nomatous nodules.
In agreement with Abdel Razek et al. (6) who found that
The mean ADC value of malignant solitary thyroid nodules
was 0.73 ± 0.19 · 10-3 mm2/s and of benign nodules was
1.8 ± 0.27 · 10-3 mm2/s. The mean ADC values of malignant
nodules were signiﬁcantly lower than those of benign ones.
There were no signiﬁcant differences between the mean ADC
values of various malignant thyroid nodules, but there were
signiﬁcant differences between the subtypes of benign thyroid
nodules. An ADC value of 0.98 · 10-3 mm2/s was proved as
a cutoff value differentiating between benign and malignant
nodules.
In our results the ADC value of inﬂammatory parotid was
1.9 · 10-3 mm2/s, while the mean ADC value of the parotid
cancer patients 0.7 ± 0.17 · 10-3 mm2/s, in agreement with
Habermann et al. (17) who revealed ADC values of2.14-3 + 0.11-3, 0.85-3 ± 0.1-3, and 1.04-3 ± 0.3 mm/s in pleo-
morphic adenomas, Warthin tumors, and mucoepidermoid
carcinomas, respectively, with statistically signiﬁcant different
ADC values in comparison with all other evaluated tumors
and also among each other. There was no statistical difference
in ADC values among all of the other primary malignant
parotid gland tumors.
Two cases of laryngeal carcinomas were done in this study
but the complex structure of the larynx leading to susceptibil-
ity artifact however ADC measurement does not affected
which mean measuring 0.9 ± 0.06 · 10-3 mm2/s. These agree
with the results of Shang et al. (18) as they study the Differen-
tiation between Laryngeal Carcinomas and Precancerous Le-
sions by Diffusion-Weighted Magnetic Resonance Imaging
however we need further study with larger number of cases.
The limitation of this study is signal to noise ratio in diffu-
sion weighted images with increasing b value with slight local
susceptibility artifacts, chemical shift artifacts, and ghosts in
the phase-encoding direction while not affecting ADC value
calculation.
Also relatively low number of cases decreases the accuracy
of statistical analysis.
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